| IC 35-48-2-1 |
NARCOTIC NEWS
Drug Law in Indiana IC 35-48-2-1
Drug Law in Indiana IC 35-48-2-1
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Considerations of board in determinations on substances; controlled
substances advisory committee; exclusion of a nonnarcotic substance
from schedule
substances advisory committee; exclusion of a nonnarcotic substance
from schedule
Sec. 1. (a) The board shall administer this article and may recommend to the
general assembly the addition, deletion, or rescheduling of all substances
listed in the schedules in sections 4, 6, 8, 10, and 12 of this chapter by
submitting in an electronic format under IC 5-14-6 a report of such
recommendations to the legislative council. In making a determination
regarding a substance, the board shall consider the following:
(1) The actual or relative potential for abuse.
(2) The scientific evidence of its pharmacological effect, if known.
(3) The state of current scientific knowledge regarding the substance.
(4) The history and current pattern of abuse.
(5) The scope, duration, and significance of abuse.
(6) The risk to public health.
(7) The potential of the substance to produce psychic or physiological
dependence liability.
(8) Whether the substance is an immediate precursor of a substance already
controlled under this article.
(b) After considering the factors enumerated in subsection (a), the board shall
make findings and recommendations concerning the control of the substance
if it finds the substance has a potential for abuse.
(c) If the board finds that a substance is an immediate precursor, substances
which are precursors of the controlled precursor shall not be subject to control
solely because they are precursors of the controlled precursor.
(d) If any substance is designated or rescheduled to a more restrictive
schedule as a controlled substance under federal law and notice is given to the
board, the board shall recommend similar control of the substance under this
article in the board's report to the general assembly, unless the board objects
to inclusion or rescheduling. In that case, the board shall publish the reasons
for objection and afford all interested parties an opportunity to be heard. At the
conclusion of the hearing, the board shall publish its findings.
(e) If a substance is rescheduled to a less restrictive schedule or deleted as a
controlled substance under federal law, the substance is rescheduled or
deleted under this article. If the board objects to inclusion, rescheduling, or
deletion of the substance, the board shall notify the chairman of the legislative
council not more than thirty (30) days after the federal law is changed and the
substance may not be rescheduled or deleted until the conclusion of the next
complete session of the general assembly. The notice from the board to the
chairman of the legislative council must be published.
(f) There is established a sixteen (16) member controlled substances advisory
committee to serve as a consultative and advising body to the board in all
matters relating to the classification, reclassification, addition to, or deletion
from of all substances classified as controlled substances in schedules I to IV
or substances not controlled or yet to come into being. In addition, the advisory
committee shall conduct hearings and make recommendations to the board
regarding revocations, suspensions, and restrictions of registrations as
provided in IC 35-48-3-4. All hearings shall be conducted in accordance with IC
4-21.5-3. The advisory committee shall be made up of:
(1) two (2) physicians licensed under IC 25-22.5, one (1) to be elected by the
medical licensing board of Indiana from among its members and one (1) to be
appointed by the governor;
(2) two (2) pharmacists, one (1) to be elected by the state board of pharmacy
from among its members and one (1) to be appointed by the governor;
(3) two (2) dentists, one (1) to be elected by the state board of dentistry from
among its members and one (1) to be appointed by the governor;
(4) the state toxicologist or the designee of the state toxicologist;
(5) two (2) veterinarians, one (1) to be elected by the state board of veterinary
medical examiners from among its members and one (1) to be appointed by
the governor;
(6) one (1) podiatrist to be elected by the board of podiatric medicine from
among its members;
(7) one (1) advanced practice nurse with authority to prescribe legend drugs as
provided by IC 25-23-1-19.5 who is:
(A) elected by the state board of nursing from among the board's members; or
(B) if a board member does not meet the requirements under IC 25-23-1-19.5
at the time of the vacancy on the advisory committee, appointed by the governor;
(8) the superintendent of the state police department or the superintendent's
designee;
(9) three (3) members appointed by the governor who have demonstrated
expertise concerning controlled substances; and
(10) one (1) member appointed by the governor who is a psychiatrist with
expertise in child and adolescent psychiatry.
(g) All members of the advisory committee elected by a board shall serve a
term of one (1) year and all members of the advisory committee appointed by
the governor shall serve a term of four (4) years. Any elected or appointed
member of the advisory committee, may be removed for cause by the authority
electing or appointing the member. If a vacancy occurs on the advisory
committee, the authority electing or appointing the vacating member shall elect
or appoint a successor to serve the unexpired term of the vacating member.
The board shall acquire the recommendations of the
advisory committee pursuant to administration over the controlled substances
to be or not to be included in schedules I to V, especially in the implementation
of scheduled substances changes as provided in subsection (d).
(h) Authority to control under this section does not extend to distilled spirits,
wine, or malt beverages, as those terms are defined or used in IC 7.1, or to
tobacco.
(i) The board shall exclude any nonnarcotic substance from a schedule if that
substance may, under the Federal Food, Drug, and Cosmetic Act or state law,
be sold over the counter without a prescription.
As added by Acts 1976, P.L.148, SEC.7. Amended by Acts 1977, P.L.344,
SEC.1; P.L.137-1985, SEC.17; P.L.200-1987, SEC.4; P.L.188-1989, SEC.4;
P.L.33-1993, SEC.73; P.L.163-1994, SEC.2; P.L.177-1997, SEC.8;
P.L.14-2000, SEC.77; P.L.107-2002, SEC.31; P.L.28-2004, SEC.178
general assembly the addition, deletion, or rescheduling of all substances
listed in the schedules in sections 4, 6, 8, 10, and 12 of this chapter by
submitting in an electronic format under IC 5-14-6 a report of such
recommendations to the legislative council. In making a determination
regarding a substance, the board shall consider the following:
(1) The actual or relative potential for abuse.
(2) The scientific evidence of its pharmacological effect, if known.
(3) The state of current scientific knowledge regarding the substance.
(4) The history and current pattern of abuse.
(5) The scope, duration, and significance of abuse.
(6) The risk to public health.
(7) The potential of the substance to produce psychic or physiological
dependence liability.
(8) Whether the substance is an immediate precursor of a substance already
controlled under this article.
(b) After considering the factors enumerated in subsection (a), the board shall
make findings and recommendations concerning the control of the substance
if it finds the substance has a potential for abuse.
(c) If the board finds that a substance is an immediate precursor, substances
which are precursors of the controlled precursor shall not be subject to control
solely because they are precursors of the controlled precursor.
(d) If any substance is designated or rescheduled to a more restrictive
schedule as a controlled substance under federal law and notice is given to the
board, the board shall recommend similar control of the substance under this
article in the board's report to the general assembly, unless the board objects
to inclusion or rescheduling. In that case, the board shall publish the reasons
for objection and afford all interested parties an opportunity to be heard. At the
conclusion of the hearing, the board shall publish its findings.
(e) If a substance is rescheduled to a less restrictive schedule or deleted as a
controlled substance under federal law, the substance is rescheduled or
deleted under this article. If the board objects to inclusion, rescheduling, or
deletion of the substance, the board shall notify the chairman of the legislative
council not more than thirty (30) days after the federal law is changed and the
substance may not be rescheduled or deleted until the conclusion of the next
complete session of the general assembly. The notice from the board to the
chairman of the legislative council must be published.
(f) There is established a sixteen (16) member controlled substances advisory
committee to serve as a consultative and advising body to the board in all
matters relating to the classification, reclassification, addition to, or deletion
from of all substances classified as controlled substances in schedules I to IV
or substances not controlled or yet to come into being. In addition, the advisory
committee shall conduct hearings and make recommendations to the board
regarding revocations, suspensions, and restrictions of registrations as
provided in IC 35-48-3-4. All hearings shall be conducted in accordance with IC
4-21.5-3. The advisory committee shall be made up of:
(1) two (2) physicians licensed under IC 25-22.5, one (1) to be elected by the
medical licensing board of Indiana from among its members and one (1) to be
appointed by the governor;
(2) two (2) pharmacists, one (1) to be elected by the state board of pharmacy
from among its members and one (1) to be appointed by the governor;
(3) two (2) dentists, one (1) to be elected by the state board of dentistry from
among its members and one (1) to be appointed by the governor;
(4) the state toxicologist or the designee of the state toxicologist;
(5) two (2) veterinarians, one (1) to be elected by the state board of veterinary
medical examiners from among its members and one (1) to be appointed by
the governor;
(6) one (1) podiatrist to be elected by the board of podiatric medicine from
among its members;
(7) one (1) advanced practice nurse with authority to prescribe legend drugs as
provided by IC 25-23-1-19.5 who is:
(A) elected by the state board of nursing from among the board's members; or
(B) if a board member does not meet the requirements under IC 25-23-1-19.5
at the time of the vacancy on the advisory committee, appointed by the governor;
(8) the superintendent of the state police department or the superintendent's
designee;
(9) three (3) members appointed by the governor who have demonstrated
expertise concerning controlled substances; and
(10) one (1) member appointed by the governor who is a psychiatrist with
expertise in child and adolescent psychiatry.
(g) All members of the advisory committee elected by a board shall serve a
term of one (1) year and all members of the advisory committee appointed by
the governor shall serve a term of four (4) years. Any elected or appointed
member of the advisory committee, may be removed for cause by the authority
electing or appointing the member. If a vacancy occurs on the advisory
committee, the authority electing or appointing the vacating member shall elect
or appoint a successor to serve the unexpired term of the vacating member.
The board shall acquire the recommendations of the
advisory committee pursuant to administration over the controlled substances
to be or not to be included in schedules I to V, especially in the implementation
of scheduled substances changes as provided in subsection (d).
(h) Authority to control under this section does not extend to distilled spirits,
wine, or malt beverages, as those terms are defined or used in IC 7.1, or to
tobacco.
(i) The board shall exclude any nonnarcotic substance from a schedule if that
substance may, under the Federal Food, Drug, and Cosmetic Act or state law,
be sold over the counter without a prescription.
As added by Acts 1976, P.L.148, SEC.7. Amended by Acts 1977, P.L.344,
SEC.1; P.L.137-1985, SEC.17; P.L.200-1987, SEC.4; P.L.188-1989, SEC.4;
P.L.33-1993, SEC.73; P.L.163-1994, SEC.2; P.L.177-1997, SEC.8;
P.L.14-2000, SEC.77; P.L.107-2002, SEC.31; P.L.28-2004, SEC.178